Cargando…
Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775857/ https://www.ncbi.nlm.nih.gov/pubmed/31632008 http://dx.doi.org/10.2147/IJN.S231687 |
| _version_ | 1783456336344776704 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6775857 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67758572019-10-18 Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum] Int J Nanomedicine Corrigendum Dove 2019-09-27 /pmc/articles/PMC6775857/ /pubmed/31632008 http://dx.doi.org/10.2147/IJN.S231687 Text en © 2019 Gomari et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Corrigendum Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum] |
| title | Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum] |
| title_full | Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum] |
| title_fullStr | Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum] |
| title_full_unstemmed | Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum] |
| title_short | Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum] |
| title_sort | targeted delivery of doxorubicin to her2 positive tumor models [corrigendum] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775857/ https://www.ncbi.nlm.nih.gov/pubmed/31632008 http://dx.doi.org/10.2147/IJN.S231687 |